Antimicrobial susceptibility of invasive pneumococcal isolates from a region in south-west Sweden 1998-2001

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 1, 2007, Pages 19-27

  Backhaus, Erik ^a   Berg, Stefan ^b   Trollfors, Birger ^b   Andersson, Rune ^a   Persson, Elisabet ^b   Claesson, Berndt E B ^a   Larsson, Peter ^c   Ek, Elisabeth ^c   Jonsson, Lars ^d   Rådberg, Gunilla ^e   Johansson, Siv ^f   Ripa, Torvald ^f   Karlsson, Diana ^g   Andersson, Kerstin ^a  

^a SKARABORG HOSPITAL   (Sweden)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d BORÅS HOSPITAL   (Sweden)

^e UDDEVALLA HOSPITAL   (Sweden)

^f HALMSTAD HOSPITAL   (Sweden)

^g UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MOXIFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLINICAL FEATURE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; SEROTYPE; STREPTOCOCCUS; SWEDEN; TEST STRIP;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

EID: 33847129993     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600895043     Document Type: Article

References (37)

1. Low, DE. (2005) Changing trends in antimicrobial-resistant pneumococci: it is not all bad news. Clin Infect Dis, 41, p. S228.
2. Hausdorff, WP, Feikin, DR and Klugman, KP. (2005) Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis, 5, pp. 83-93.
3. Arason, VA, Kristinsson, KG, Sigurdsson, JA, Stefansdottir, G., Molstad, S. and Gudmundsson, S. (1996) Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Br Med J, 313, pp. 387-391.
4. Melander, E., Ekdahl, K., Jonsson, G. and Molstad, S. (2000) Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J, 19, pp. 1172-1177.
5. Vanderkooi, OG, Low, DE, Green, K., Powis, JE and McGeer, A. (2005) Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis, 40, pp. 1288-1297.
6. Ekdahl, K. and Kamme, C. (1994) Increasing resistance to penicillin in Streptococcus pneumoniae in southern Sweden. Scand J Infect Dis, 26, pp. 301-305.
7. Nilsson, P. and Laurell, MH. (2005) Impact of socioeconomic factors and antibiotic prescribing on penicillin-non-susceptible Streptococcus pneumoniae in the city of Malmo. Scand J Infect Dis, 37, pp. 436-441.
8. Nilsson, P. (2005) Penicillin-non-susceptible Streptococcus pneumoniae in Malmö, Sweden: Aspects of epidemiology, microbiology and genetics, Universitetssjukhuset MAS, Malmö
9. Ekdahl, K., Martensson, A. and Kamme, C. (1998) Bacteraemic pneumococcal infections in southern Sweden 1981-96: Trends in incidence, mortality, age distribution, serogroups and penicillin resistance. Scand J Infect Dis, 30, pp. 257-262.
10. Klugman, KP. (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Rev, 3, pp. 171-196.
11. Hedlund, J., Svenson, SB, Kalin, M., Henrichsen, J.,Olsson-Liljequist, B. and Mollerberg, G. (1995) Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis, 21, pp. 948-953.
12. Giesecke, J. and Fredlund, H. (1997) Increase in pneumococcal bacteraemia in Sweden. Lancet, 349, pp. 699-700.
13. Dahl, MS, Trollfors, B., Claesson, BA, Brandberg, LL and Rosengren, A. (2001) Invasive pneumococcal infections in south-west Sweden: A second follow-up period of 15 y. Scand J Infect Dis, 33, pp. 667-672.
14. Normark, BH, Ortqvist, A., Kalin, M., Olsson-Liljequist, B., Hedlund, J. and Svenson, SB (2001) Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children. Scand J Infect Dis, 33, pp. 848-850.
15. Normark, B Henriques, Kalin, M., Ortqvist, A., Akerlund, T., Liljequist, BO and Hedlund, J. (2001) Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis, 184, pp. 861-869.
16. Burman, LA, Trollfors, B., Norrby, R., Falsen, E., Haidl, S. and Henrichsen, J. (1986) Serotype distribution of Streptococcus pneumoniae strains isolated from blood and cerebrospinal fluid in Sweden. Scand J Infect Dis, 18, pp. 45-48.
17. Berg, S., Trollfors, B., Persson, E., Backhaus, E. and Larsson, P. (2006) Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics. Scand J Infect Dis, 38, pp. 427-432.
18. Lund, E. (1978) Laboratory Diagnosis, Serology and Epidemiology of Streptococcus pneumoniae, Academic Press, New York
19. Klugman, KP. (2002) The successful clone: The vector of dissemination of resistance in Streptococcus pneumoniae. J Antimicrob Chemother, 50, pp. 1-5.
20. Melander, E., Molstad, S., Persson, K., Hansson, HB, Soderstrom, M. and Ekdahl, K. (1998) Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis, 17, pp. 834-838.
21. Metlay, JP, Hofmann, J., Cetron, MS, Fine, MJ, Farley, MM and Whitney, C. (2000) Impact of penicillin susceptibility on medical outcomes for adult patients with bacteraemic pneumococcal pneumonia. Clin Infect Dis, 30, pp. 520-528.
22. Rothermel, CD. (2004) Penicillin and macrolide resistance in pneumococcal pneumonia: Does in vitro resistance affect clinical outcomes?. Clin Infect Dis, 38, p. S346.
23. Pletz, MW, McGee, L., Burkhardt, O., Lode, H. and Klugman, KP. (2005) Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy. Eur J Clin Microbiol Infect Dis, 24, pp. 58-60.
24. Sandgren, A., Sjostrom, K., Olsson-Liljequist, B., Christensson, B., Samuelsson, A. and Kronvall, G. (2004) Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis, 189, pp. 785-796.
25. Bruinsma, N., Kristinsson, KG, Bronzwaer, S., Schrijnemakers, P., Degener, J. and Tiemersma, E. (2004) Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother, 54, pp. 1045-1050.
26. Doern, GV, Heilmann, KP, Huynh, HK, Rhomberg, PR, Coffman, SL and Brueggemann, AB. (2001) Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother, 45, pp. 1721-1729.
27. Cars, O., Molstad, S. and Melander, A. (2001) Variation in antibiotic use in the European Union. Lancet, 357, pp. 1851-1853.
28. Hedlund, J., Sorberg, M., Normark, B Henriques and Kronvall, G. (2003) Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis, 35, pp. 452-458.
29. Borres, MP, Alestig, K., Krantz, I., Larsson, P., Norvenius, G. and Stenqvist, K. (2000) Carriage of penicillin-susceptible and non-susceptible pneumococci in healthy young children in Goteborg, Sweden. J Infect, 40, pp. 141-144.
30. Konradsen, HB and Kaltoft, MS. (2002) Invasive pneumococcal infections in Denmark from 1995 to 1999: Epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol, 9, pp. 358-365.
31. Pedersen, MK, Hoiby, EA, Froholm, LO, Hasseltvedt, V., Lermark, G. and Caugant, DA. (2004) Systemic pneumococcal disease in Norway 1995-2001: capsular serotypes and antimicrobial resistance. Epidemiol Infect, 132, pp. 167-175.
32. Appelbaum, PC. (1992) Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin Infect Dis, 15, pp. 77-83.
33. Talbot, TR, Poehling, KA, Hartert, TV, Arbogast, PG, Halasa, NB and Mitchel, E. (2004) Reduction in high rates of antibiotic-non-susceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis, 39, pp. 641-648.
34. Stephens, DS, Zughaier, SM, Whitney, CG, Baughman, WS, Barker, L. and Gay, K. (2005) Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet, 365, pp. 855-863.
35. Eriksson, M., Henriques, B. and Ekdahl, K. (2000) Epidemiology of pneumococcal infections in Swedish children. Acta Paediatr Suppl, 89, pp. 35-39.
36. Lovgren, M., Dell'Acqua, L., Palacio, R., Echaniz-Aviles, G., Soto-Nogueron, A. and Castaneda, E. (1999) Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E-test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group. J Clin Microbiol, 37, pp. 215-217.
37. Jorgensen, JH, Howell, AW and Maher, LA. (1991) Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test. J Clin Microbiol, 29, pp. 109-114.